Yang Zhang
- Molecular Biology top 1%
- Biomedical Engineering top 0.2%
- Biomaterials top 0.2%
- Materials Chemistry top 2%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Gang LiuXiaohong ChenChengchao ChuEn RenXin PangErich GulbinsHuirong LinShi‐Wen Huang
- Topics
- Nanoplatforms for cancer theranostics (82 papers)Nanoparticle-Based Drug Delivery (47 papers)Lung Cancer Treatments and Mutations (39 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yang Zhang
574 papers receiving 13.5k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Molecular Biology 4.5k
- Biomedical Engineering 4.2k
- Biomaterials 2.3k
- Materials Chemistry 2.1k
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by Yang Zhang
This map shows the geographic impact of Yang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Zhang more than expected).
Fields of papers citing papers by Yang Zhang
This network shows the impact of papers produced by Yang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Zhang. The network helps show where Yang Zhang may publish in the future.
Co-authorship network of co-authors of Yang Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Yang Zhang. A scholar is included among the top collaborators of Yang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Zhang. Yang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 51 | |
| 10 | 2 | |
| 11 | 8 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 23 | |
| 15 | 6 | |
| 16 | 21 | |
| 17 | 3 | |
| 18 | 7 | |
| 19 | 10 | |
| 20 | The efficacy and safety of anlotinib treatment for advanced lung cancer | 1 |
About Yang Zhang
Yang Zhang is a scholar working on Biomaterials, Hepatology and Oncology, having authored 602 papers that have together received 13.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (82 papers), Nanoparticle-Based Drug Delivery (47 papers) and Lung Cancer Treatments and Mutations (39 papers). The work is most often cited by research in Biomaterials (2.3k citations), Biomedical Engineering (4.2k citations) and Cancer Research (1.1k citations). Yang Zhang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Gang Liu, Xiaohong Chen, Chengchao Chu, En Ren, Xin Pang, Erich Gulbins, Huirong Lin, Shi‐Wen Huang, Krishna M. Boini and Gan Lin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.